深圳康泰生物制品股份有限公司 focuses on the research, production, and sales of human vaccines. It has established itself as a significant player in the innovative biopharmaceutical industry with various vaccine technologies and products.

深圳康泰生物制品股份有限公司

Shenzhen Kangtai Biological Products Co., Ltd. researches, develops, produces, and sells various types of human vaccines in China. The company's products include cell-free whitebait b-type haemophilus influenzae combined vaccine, SARS-COV-2 vaccine, recombinant hepatitis B vaccine, 23-valent pneumococcal polysaccharide vaccine, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccine, haemophilus influenzae type b conjugate vaccine, measles and rubella combined with live attenuated vaccine, 13-valent pneumococcal conjugate vaccine, rabies vaccine, inactivated poliomyelitis vaccine, and HIB conjugate vaccine. It has an agreement between YTB and Yong Tai Berhad in relation to the development and commercialization of Covid-19 inactivated vaccine in Malaysia. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is based in Shenzhen, China.

Shenzhen Kangtai Biological Products Co., Ltd.

深圳康泰生物制品股份有限公司 | 118 followers on LinkedIn. 创造更好的疫苗，造福人类健康。
Create better vaccines to benefit human health. | Founded in 1992, BioKangtai champions innovation through key scientific research and technology projects, boosting our R&amp;D and industrial capabilities. Follow us for the latest updates! Create better vaccines to benefit human health.

深圳康泰生物制品股份有限公司 - 安环总监

Chen Shuigen

深圳康泰生物制品股份有限公司 - 地区销售主管

陈淑芳

BD manager, BioKangtai

Xue Li

深圳康泰生物制品股份有限公司 （股票代码:300601）

任广

We are pleased to announce that our brand new website is about to go live! 🎉 Get ready for an exciting experience filled with product development and industry news. 🌐 Established in 1992, Shenzhen Kangtai Biological Products Co., Ltd. is a company dedicated to the research, development and production of biological products to protect human health. Please continue to follow updates and become one of the first explorers!

3006

COM:BIOKANGTAI

深圳康泰生物制品股份有限公司

Last Close

19.05

22/11 07:04

Market Cap

16.99B

Beta: -

Volume Today

15.14M

Avg: -

locale

market

industry

website

crunchbase

linkedin

ipo date

peer of

Metrics